Globalization of Pharmaceutics Edu… - Form 990 Financial Data

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

1998

Legal Domicile

Principal Officer

JEFFREY KRISE

Phone

7858642626

Tax Period

2023-01-01 to 2023-12-31

Globalization of Pharmaceutics Education Network Inc, founded in 1998, is a micro nonprofit in the Education sector that reported $42K in total revenue in fiscal year 2023. Revenue fell 65% from the prior year — a significant decline worth monitoring. The organization ran a surplus of $26K, a strong 60% operating margin.

Mission

TO FOSTER AND FACILITATE INTERNATIONAL SCIENTIFIC EXCHANGE IN THE PHARMACEUTICAL SCIENCES.

Program Service Accomplishments

Program 1

Expenses: $9,763

Organize a bi-annual conference to provide graduate students and postdoctoral fellows with increased international education and research experience in order to prepare them for the new globalized...

Organize a bi-annual conference to provide graduate students and postdoctoral fellows with increased international education and research experience in order to prepare them for the new globalized pharmaceutical industry.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2023)

Revenue Breakdown

Contributions & Grants $45,500

Program Service Revenue $0

Investment Income $-3,035

Other Revenue $0

TOTAL REVENUE $42,465

Expense Breakdown

Grants Paid $8,573

Salaries & Benefits $0

Fundraising Expenses $0

Program Expenses $9,763

Other Expenses $8,375

TOTAL EXPENSES $16,948

Year-over-Year Comparison

	2023	2022	Change
Revenue	$42,465	$121,825	-0.7%
Expenses	$16,948	$142,254	-0.9%
Net Income	$25,517	$-20,429	-2.2%

Key Indicators

✗ Grants to Organizations ✓ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✓ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

N/A

Volunteers

Governance Policies

✗ Conflict of Interest Policy

✗ Whistleblower Policy

✗ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

Total Directors

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
Ronald T Borchardt	Senior Advisor	1.00	Officer Director	$0	$0	$0
KENNETH L AUDUS	CHAIR	1.00	Officer Director	$0	$0	$0
CHRISTEL BERGSTROM	Director	1.00	Director	$0	$0	$0
TERUNA SIAHAAN	ViceCHAIR, SECR	1.00	Officer Director	$0	$0	$0
YOSHI TAKAKURA	MEMBER AT LARGE	1.00	Officer Director	$0	$0	$0
JOSEPH NICOLAZZO	Director	1.00	Director	$0	$0	$0
PATRICK AUGUSTIJNS	Director	1.00	Director	$0	$0	$0
JEFF KRISE	Treasurer	1.00	Officer Director	$0	$0	$0
KIM BROUWER	Director	1.00	Director	$0	$0	$0
CHRISTIAN SCHONEICH	Director	1.00	Director	$0	$0	$0
BIANCA LIEDERER	Director	1.00	Director	$0	$0	$0
M Vitoria Bentley	Member-at-Large	1.00	Director	$0	$0	$0

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2025	No data	No data	No data	No data
2024	No data	No data	No data	No data
2023	$42,465	$16,948	$780,367	$25,517
2022	$121,825	$142,254	$754,565	$-20,429
2021	$19,694	$11,579	$776,276	$8,115
2020	$142,824	$40,238	$769,029	$102,586
2019	$31,851	$23,306	$667,538	$8,545
2018	$225,686	$69,687	$659,163	$155,999

Globalization of Pharmaceutics Education Network Inc